Navigation Links
Varian Medical Systems Establishes Radiotherapy Training Center and Clinical Help Desk in Tokyo, Japan
Date:1/11/2012

TOKYO, Jan. 11, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), a world leader in radiotherapy equipment and software for the treatment of cancer, has established its first education center in Tokyo, Japan, to train radiation oncologists, medical physicists, and technologists who work with Varian's cancer treatment systems. In addition, the company has established a clinical contact center (Help Desk), to provide phone support for Varian's customers in Japan.

These services are housed in a new facility that is conveniently located in central Tokyo.  The training center will begin offering courses to radiation oncology clinical professionals in February 2012.  It features a computer-equipped classroom with 20 work stations and state of the art audio/visual equipment, as well as two customer lounges. 

"Radiotherapy is widely recognized as an efficient treatment for cancer.  The number of cancer patients who received radiotherapy treatments in Japan doubled over the last decade, rising from roughly 100,000 per year in the late 1990s to over 250,000 today," said Makoto Yamada, sales manager for Varian in Japan, citing statistics that have been published by the Japanese Society for Therapeutic Radiology and Oncology (JASTRO).  "JASTRO predicts that the number of Japanese people needing access to radiotherapy services will rise to 360,000 by 2015.  But there is a shortage of trained clinical professionals in Japan.  Varian's new education center represents our commitment to helping address the expanding need for training in this area." 

The field of radiation oncology has evolved over the last decade, and now requires the skillful use of complex technology that enables doctors to precisely target tumors while minimizing exposure of surrounding healthy tissues.  "Varian's training center will help clinicians d
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Pharmavite LLC announced that Timothy "Tim" ... effective immediately. Toll recently served as Pharmavite,s executive vice ... management, private label and sales administration in ... role, Toll will expand his responsibilities to include international ... "Toll,s appointment to chief customer officer is part of ...
(Date:7/23/2014)... , July 23, 2014 Research ... the "Global Electrophysiology Ablation Catheters Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Catheter ablation ... or destroy faulty electrical pathways from sections of ... known as cardiac arrhythmias). Cardiac arrhythmias can be ...
(Date:7/23/2014)... NEW YORK , July 23, 2014 /PRNewswire/ ... Delray Beach, Fla. , is an emerging ... molecular diagnostic systems for bio-threat detection and rapid ... system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), ... of Homeland Security ("DHS") Science & Technology directorate, ...
Breaking Medicine Technology:Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2
... 31, 2011 Mevion Medical Systems announced today it ... S. Lee Kling Center for Proton Therapy at the ... University School of Medicine in St. Louis MO. This ... of the first MEVION S250 proton accelerator module and ...
... 31, 2011 Royal Philips Electronics (AEX: PHI, NYSE: ... full-field digital mammography (FFDM) solution that offers a lower ... compromising image quality. The addition of MicroDose to Philips, ... for the company,s focus on women,s health care, and ...
Cached Medicine Technology:Mevion Medical Systems Delivers the World's First Superconducting Synchrocyclotron for Proton Therapy to Barnes Jewish Hospital 2Philips Enters North American Mammography Market, Underscoring its Global Commitment to Women's Health Care 2Philips Enters North American Mammography Market, Underscoring its Global Commitment to Women's Health Care 3Philips Enters North American Mammography Market, Underscoring its Global Commitment to Women's Health Care 4
(Date:7/23/2014)... (PRWEB) July 23, 2014 Home ... in-home care for seniors, is proud to announce the ... featuring experts in a wide range of health and ... social worker and award-winning author Nancy Kriseman, and will ... ways to prevent burnout by becoming more self-aware. In ...
(Date:7/23/2014)... July 23, 2014 (HealthDay News) -- Regularly checking the ... stroke, researchers report. "Screening pulse is the method ... over age 65 who have never had a stroke. ... noninvasive and easy way to identify people who might ... said study author Dr. Bernd Kallmunzer, of Erlangen University ...
(Date:7/23/2014)... of Biomedical Imaging and Bioengineering will host its second ... 2014 on the NIH campus. There will be ten ... breadth of NIBIB-funded research. , WHO: ... Rhodopsins as Optical Voltage Sensor, Quyen Nguyen, Univ. ... Nerve Imaging during Surgery, ...
(Date:7/23/2014)... Global Cardio Care, Inc., a management company ... is celebrating the 100th birthday of Albert Weber, ... center. , Weber has been plagued with angina ... therapy since 1999, he no longer suffers from either ... Cardio Care, introduced the Sara Soulati Health For ...
(Date:7/23/2014)... Fragile X syndrome ( FXS ) is a genetic ... behaviors on the autistic spectrum, as well as cognitive ... mental impairment and the most common cause of autism. ... Riverside have published a study that sheds ... Appearing online today (July 23) in the Journal ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3
... one day as part of cancer-fighting arsenal, but more study ... -- A new study in mice suggests that a transcription ... target for cancer vaccines. , A transcription factor is a ... from the DNA to messenger RNA. This particular factor, ...
... control of disease when chemo is targeted to specific ,molecular ... number one cancer killer, lung cancer, may be more susceptible ... with key genetic traits, a new study finds. , The ... overall, 46 percent of patients with stage IV (advanced) non-small ...
... Predicting breast cancer spread from a sentinel lymph node removed ... there are still many false negatives, which means the node, ... but metastasis can still occur in the patient. The sentinel ... cancer spreads to. Now, researchers from Georgetown Lombardi Comprehensive ...
... ... interactive feature, Keilhauer,s new microsite for Beam Seating makes specifying beam seating an easy ... ... Beam seating expand the original series to such an extent it can hardly be ...
... ... face trouble exercising and lifestyle restrictions, and more severe problems, like sleep apnea, can increase ... ... patients who report breathing problems are diagnosed with sinusitis, and many of these people find ...
... ... Cost Effective Occupational Health Care , ... Pittsburgh, PA (PRWEB) April 18, 2010 -- Allegheny Medical Integrated Health ... of physicians and health care professionals whose mission is to build better health for ...
Cached Medicine News:Health News:Vaccine Stops Tumor Spread in Mice 2Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 2Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 3Health News:Routine breast cancer biopsy might predict lymph node cancer spread 2Health News:Keilhauer's Expanded Beam Seating Launches With its Own Microsite 2Health News:Keilhauer's Expanded Beam Seating Launches With its Own Microsite 3Health News:Breathing Obstructions Caused by Sinusitis can Require Surgery, says Denver's Nose Doc 2Health News:Breathing Obstructions Caused by Sinusitis can Require Surgery, says Denver's Nose Doc 3Health News:Allegheny Medical's Occupational Health Services Helps Employers Build a Healthier Workforce 2Health News:Allegheny Medical's Occupational Health Services Helps Employers Build a Healthier Workforce 3
NS2000 Bipolar Generator provides precise coagulation without tissue sticking....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Standard bipolar coagulator...
Medicine Products: